• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyridazines and derivatives

Methyl 6-chloropyridazine-4-carboxylate (CAS No. 1093860-48-0): A Versatile Building Block in Modern Organic Synthesis

The compound Methyl 6-chloropyridazine-4-carboxylate (CAS No. 1093860-48-0) has emerged as a critical intermediate in pharmaceutical and agrochemical research. Its unique pyridazine core and functional groups make it a valuable scaffold for designing novel bioactive molecules. With the increasing demand for heterocyclic compounds in drug discovery, this methyl ester derivative has gained significant attention from medicinal chemists worldwide.

Recent studies highlight the growing importance of 6-chloropyridazine derivatives in developing kinase inhibitors and antimicrobial agents. The presence of both chloro and ester substituents at positions 6 and 4 respectively provides excellent opportunities for further functionalization through cross-coupling reactions or nucleophilic substitutions. This versatility aligns perfectly with current trends in fragment-based drug design and click chemistry applications.

From a synthetic chemistry perspective, Methyl 6-chloropyridazine-4-carboxylate serves as a key precursor for preparing various pyridazine-4-carboxylic acid derivatives. The compound's stability under standard laboratory conditions and good solubility in common organic solvents make it particularly attractive for high-throughput screening applications. Researchers frequently employ this building block in the synthesis of biologically active heterocycles, especially those targeting neurological disorders and metabolic diseases.

The compound's molecular structure features an interesting electronic configuration that enables diverse reactivity patterns. The electron-withdrawing carboxylate group at position 4 activates the ring for nucleophilic aromatic substitution, while the chloro substituent at position 6 serves as an excellent leaving group for subsequent modifications. This dual functionality explains why 1093860-48-0 appears in numerous patent applications related to small molecule therapeutics.

In the context of green chemistry advancements, Methyl 6-chloropyridazine-4-carboxylate has been successfully utilized in catalyzed coupling reactions with reduced environmental impact. Modern synthetic protocols often employ this compound in palladium-catalyzed cross-couplings or microwave-assisted synthesis, reflecting the pharmaceutical industry's shift toward more sustainable production methods. These applications address common search queries regarding eco-friendly heterocycle synthesis and atom-efficient reactions.

Analytical characterization of CAS 1093860-48-0 typically involves advanced techniques such as HPLC-MS and NMR spectroscopy. The compound exhibits characteristic spectral patterns that facilitate its identification in complex reaction mixtures. Quality control protocols for this material emphasize purity assessment through chromatographic methods, responding to industry demands for high-purity intermediates in drug development pipelines.

The thermal stability and crystallographic properties of Methyl 6-chloropyridazine-4-carboxylate have been subjects of recent investigations. These studies provide valuable data for process chemists optimizing scale-up procedures and formulation development. The compound's physicochemical parameters, including melting point and partition coefficient, make it particularly suitable for designing orally bioavailable compounds - a hot topic in current medicinal chemistry research.

From a commercial perspective, the global market for pyridazine derivatives like 1093860-48-0 continues to expand. Pharmaceutical companies increasingly seek specialized chemical building blocks that can accelerate their drug discovery programs. This demand has led to improved synthetic routes and more cost-effective production methods for Methyl 6-chloropyridazine-4-carboxylate, addressing common industry challenges regarding bulk availability and supply chain reliability.

Recent patent literature reveals innovative applications of 6-chloropyridazine-4-carboxylate esters in proteolysis targeting chimera (PROTAC) development. This cutting-edge technology in targeted protein degradation has created new opportunities for such heterocyclic scaffolds. The compound's ability to serve as a linker component in these bifunctional molecules demonstrates its relevance in contemporary drug discovery platforms.

Safety considerations for handling Methyl 6-chloropyridazine-4-carboxylate follow standard laboratory protocols for organic intermediates. Proper personal protective equipment and ventilation systems are recommended when working with this compound, reflecting the broader pharmaceutical industry's emphasis on workplace safety standards. These precautions align with frequently searched topics regarding safe chemical handling practices in research laboratories.

Future research directions for CAS 1093860-48-0 may explore its potential in metal-organic frameworks (MOFs) or as a ligand in catalytic systems. The compound's structural features suggest possible applications beyond traditional medicinal chemistry, including materials science and supramolecular chemistry. Such interdisciplinary applications respond to growing interest in multifunctional organic molecules across scientific communities.

In summary, Methyl 6-chloropyridazine-4-carboxylate represents a prime example of how specialty chemicals enable innovation in life sciences. Its combination of synthetic accessibility and structural versatility ensures continued relevance in addressing current challenges in pharmaceutical development and chemical biology. As research into nitrogen-containing heterocycles advances, this compound will likely maintain its position as a valuable tool for chemists designing next-generation therapeutic agents.

• 51149-08-7(3,6-Dichloropyridazine-4-carboxylic acid)
• 1383481-40-0(3-(6-chloro-4-pyridazinyl)-Benzoic acid methyl ester)
• 34127-22-5(Ethyl 3,6-dichloropyridazine-4-carboxylate)
• 1445-54-1(Ethyl 3-chloropyridazine-4-carboxylate)
• 286946-24-5(Methyl 3,6-dichloropyridazine-4-carboxylate)
• 1023307-42-7(3-chloropyridazine-4-carboxylic acid)
• 612834-90-9(Ethyl 6-chloropyridazine-4-carboxylate)
• 1363381-53-6(Methyl 3,6-dichloro-5-methylpyridazine-4-carboxylate)
• 1256794-24-7(6-Chloropyridazine-4-carboxylic acid)
• 1445-53-0(Ethyl 3-chloro-6-methylpyridazine-4-carboxylate)